George M Milne Jr is of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 858,571 shares of AMLX, which is worth approximately $5.43 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 100,000 shares (Common Stock) at a price of $2.2 per share, resulting in proceeds of $220,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 859K
13.18% 3M change
0.4% 12M change
Total Value Held $5.43 Million

GEORGE M MILNE Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
BUY
Open market or private purchase
$220,000 $2.2 p/Share
100,000 Added 10.43%
858,571 Common Stock
Jan 25 2024
SELL
Bona fide gift
-
9,100 Reduced 1.19%
758,571 Common Stock
Jan 16 2024
SELL
Bona fide gift
-
94,350 Reduced 10.95%
767,671 Common Stock
Mar 16 2023
SELL
Open market or private sale
$1,125,599 $32.16 p/Share
35,000 Reduced 3.9%
862,021 Common Stock
Jan 06 2022
BUY
Open market or private purchase
$499,985 $19.0 p/Share
26,315 Added 10.62%
221,396 Common Stock

Also insider at

CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
GMM

George M Milne Jr

Wilmington, MA

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Track Activities on AMLX